Influence of scai and natriuretic peptide (NP) clearance receptor polymorphisms of the NP system on NP concentration in chronic heart failure

Clinical Chemistry

Volumn 53, Issue 11, 2007, Pages 1886-1890

  Vassalle, Cristina ^a   Andreassi, Maria Grazia ^a   Prontera, Concetta ^a   Fontana, Marianna ^a   Zyw, Luc ^a   Passino, Claudio ^a,b   Emdin, Michele ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE CLEARANCE RECEPTOR; NEUROHORMONE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ANP GENE; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEART EJECTION FRACTION; HEART FAILURE; HEREDITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NPRC GENE; RECEPTOR GENE; RISK FACTOR; SCAI GENE;

AGED; ATRIAL NATRIURETIC FACTOR; FEMALE; HEART FAILURE; HUMANS; MALE; MUTATION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 35648967496     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.088302     Document Type: Article

References (24)

1. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248-54.
2. Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006;290:H17-29.
3. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 2004;50:33-50.
4. Rubattu S, Ridker P, Stampfer MJ, Volpe M, Hennekens CH, Lindpaintner K. The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation 1999;100:1722-6.
5. Sarzani R, Dessi-Fulgheri P, Salvi F, Serenelli M, Spagnolo D, Cola G, et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 1999;17:1301-5.
6. Ono K, Mannami T, Baba S, Tomoike H, Suga S, Iwai N. A single-nucleotide polymorphism in C-type natriuretic peptide gene may be associated with hypertension. Hypertens Res 2002;25:727-30.
7. Gruchala M, Ciecwierz D, Wasag B, Targonski R, Dubaniewicz W, Nowak A, et al. Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J 2003;145:125-31.
8. Jortani SA, Prabhu SD, Valdes R. Strategies for developing biomarkers of heart failure. Clin Chem 2004;50:265-78.
9. Prontera C, Emdin M, Zucchelli GC, Ripoli A, Passino C, Clerico A. Natriuretic peptides (NPs): automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. Clin Chem 2003;49:1552-4.
10. Clerico A, Passino C, Emdin M. Clinical consideration and application. In: Clerico A, Endim M, eds. Natriuretic Peptides: The Hormones of the Heart. New York: Springer-Verlag, 2006:91-117.
11. Passino C, Severino S, Poletti R, Piepoli MF, Mammini C, Clerico A, et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 2006;47:1835-9.
12. Clerico A, Iervasi G, Del Chicca MG, Emdin M, Maffei S, Nannipieri M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 1998;21:170-9.
13. Masetti S, Botto N, Manfredi S, Colombo MG, Rizza A, Vassalle C, et al. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med 2003;81:488-9.
14. Rubattu S, Stanzione R, Di Angelantonio E, Zanda B, Evangelista A, Tarasi D, et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004;35:814-8.
15. Nannipieri M, Manganiello M, Pezzatini A, De Bellis A, Seghieri G, Ferrannini E. Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension. Hypertension 2001;37:1416-22.
16. Pitzalis MV, Sarzani R, Dessi-Fulgheri P, Iacoviello M, Forleo C, Lucarelli K, et al. Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. J Hypertens 2003;21:1491-6.
17. Nannipieri M, Penno G, Pucci L, Colhoun H, Motti C, Bertacca A, et al. Pronatriodilatin gene polymorphisms, microvascular permeability, and diabetic nephropathy in type 1 diabetes mellitus. J Am Soc Nephrol 1999;10:1530-41.
18. Rutledge DR, Sun Y, Ross EA. Polymorphisms within the atrial natriuretic peptide gene in essential hypertension. J Hypertens 1995;13:953-5.
19. Nannipieri M, Posadas R, Williams K, Politi E, Gonzales-Villalpando C, Stern MP, et al. Association between polymorphisms of the atrial natriuretic peptide gene and proteinuria: a population-based study. Diabetologia 2003;46:429-32.
20. Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L, et al. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 2006;48:499-505.
21. Rahmutula D, Nakayama T, Soma M, Takahashi Y, Kunimoto M, Uwabo J, et al. Association study between the variants of the human ANP gene and essential hypertension. Hypertens Res 2001;24:291-4.
22. Guo X, Cheng S, Taylor KD, Cui J, Hughes R, Quinones MJ, et al. Hypertension genes are genetic markers for insulin sensitivity and resistance. Hypertension 2005;45:799-803.
23. Yanaka N, Kotera J, Omori K. Isolation and characterization of the 5′-flanking regulatory region of the human natriuretic peptide receptor C gene. Endocrinology 1998;139:1389-400.
24. Sarzani R, Strazzullo P, Salvi F, Iacone R, Pietrucci F, Siani A, et al. Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity. Obes Res 2004;12:351-6.